Journal article
Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
- Abstract:
-
BACKGROUND: Tuberculosis (TB) remains a global health problem, with vaccination likely to be a necessary part of a successful control strategy. Results of the first Phase 2b efficacy trial of a candidate vaccine, MVA85A, evaluated in BCG-vaccinated infants were published last year. Although no improvement in efficacy above BCG alone was seen, cryopreserved samples from this trial provide an opportunity to study the immune response to vaccination in this population. METHODS: We investigated bl...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, bin, 587.6KB)
-
(Version of record, pdf, 2.4MB)
-
- Publisher copy:
- 10.1186/1471-2334-14-314
Authors
Funding
Aeras Global Tuberculosis Vaccine Foundation
More from this funder
Oxford-Emergent Tuberculosis Consortium Limited
More from this funder
Wellcome Trust
More from this funder
EU-FP7
More from this funder
Bibliographic Details
- Publisher:
- BioMed Central Publisher's website
- Journal:
- BMC infectious diseases Journal website
- Volume:
- 14
- Issue:
- 1
- Pages:
- 314
- Publication date:
- 2014-06-09
- DOI:
- EISSN:
-
1471-2334
- ISSN:
-
1471-2334
- Source identifiers:
-
469377
Item Description
- Language:
- English
- Keywords:
- Subjects:
- Pubs id:
-
pubs:469377
- UUID:
-
uuid:8bb55950-b4a3-46c2-b791-11cc745cc8ea
- Local pid:
- pubs:469377
- Deposit date:
- 2014-06-30
Terms of use
- Copyright holder:
- Matsumiya et al
- Copyright date:
- 2014
- Notes:
- © 2014 Matsumiya et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record